Tirbanibulin (KX2-391) is a highly selective Src kinase inhibitor that has demonstrated efficacy in pre-Clinicalal animal models of colon, pancreatic, prostate and breast cancer. It is a substrate-targeted kinase inhibitor. KX2-391, belongs to an emerging new family of targeted cancer treatments called protein kinase inhibitors.
Molecular Weight:
431.53
Purity:
99.67%
CAS Number:
[897016-82-9]
Formula:
C26H29N3O3
Target:
Microtubule Associated|||Src
T6345
* VAT and and shipping costs not included. Errors and price changes excepted
